Vitruviae is a startup based in the United Kingdom, 1 tracked investor.
Based in the United Kingdom, Vitruviae is a startup. Brouky records 1 investor associated with the company.
Vitruviae develops proprietary immunotherapies targeting sugars and lipids uniquely expressed on cancer cells and cancer stem cells to improve efficacy and safety in cancer treatment, with a focus on acute myeloid leukemia and solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.